Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
7.33
+0.55 (8.11%)
At close: Jan 2, 2026, 4:00 PM EST
7.34
+0.01 (0.14%)
After-hours: Jan 2, 2026, 7:51 PM EST
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $17.14 million as of January 2, 2026. Its market cap has decreased by -12.59% in one year.
Market Cap
17.14M
Enterprise Value
13.28M
1-Year Change
-12.59%
Ranking
Category
Stock Price
$7.33
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $17.14M, a decrease of -70.54%. That is a compound annual growth rate of -33.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 17.14M | 8.11% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.70B |
| Johnson & Johnson | 496.72B |
| AbbVie | 405.14B |
| UnitedHealth Group | 303.56B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 262.11B |
| Novo Nordisk | 230.76B |